Offered by: Nemours Children's Health, Jacksonville
Location: Jacksonville, Fla.
A Phase I Study of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors
To determine safety and effectiveness temozolomide, irinotecan and bevacizumab. All three of these agents have shown effectiveness in pediatric brain tumors.
Length of study is up to 2 years. Standard cancer care.
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.